Showing results (221-230 of 249) with videos related to
Sort By:
Pageof 25
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|July 2, 2015
Influence of using a single facial vein as outflow in full-face transplantation: A three-dimensional computed tomographic studyAndres Rodriguez-Lorenzo, Thorir Audolfsson, Corrine Wong, et al.Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|February 28, 2007
School grades and myopiaSeang-Mei Saw, Angela Cheng, Allan Fong, et al.Plastic and Reconstructive Surgery|June 7, 2022
Initial Experience with the PONTiS Tendon Repair System in Traumatic Upper Extremity InjuriesDaniel W Maxwell, Karan A Desai, Robert C Fang, et al.Current Problems in Cardiology|November 19, 2022
Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate EndpointsAngela Cheng-Lai, Lendita Prlesi, Sandhya Murthy, et al.Cardiology in Review|August 23, 2016
Patiromer: The First Potassium Binder Approved in Over 50 YearsBetty N Vu, Alyssa Mae De Castro, David Shottland, et al.The Journal of Investigative Dermatology|June 3, 2006
Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in miceBetsy N Perry, Baskaran Govindarajan, Sulochana S Bhandarkar, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2003
Awareness and health beliefs of women towards osteoporosisSeang-Mei Saw, Ching-Ye Hong, Jeanette Lee, et al.Histopathology|March 4, 2017
Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort studyJessica N McAlpine, Samuel C Y Leung, Angela Cheng, et al.JACC. Advances|March 30, 2026
Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary InterventionKatherine E Di Palo, Pavel Goriacko, Mark Menegus, et al.Pharmacotherapy|June 2, 2005
Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controlsAdam R Shprecher, Angela Cheng-Lai, Eileen M Madsen, et al.Pageof 25